丙戊酸减轻炎症反应并预防急性呼吸窘迫综合征,但以细菌清除为代价:大肠埃希菌肺炎小鼠模型
本研究在雄性C57BL6小鼠(n=24)中经气管滴注3×10大肠埃希菌诱导ARDS,干预组在滴注后30分钟给予丙戊酸(250 mg/kg),于3小时和6小时采血、6小时处死动物行支气管肺泡灌洗及组织取材。结果显示丙戊酸减少中性粒细胞流入肺部、降低髓过氧化物酶活性以减轻局部组织破坏,并改善肺部及全身炎症反应,从而基本预防ARDS,但肺实质细菌增殖增加。结论提示丙戊酸在临床相关细菌性ARDS模型中虽减轻宿主炎症反应,却造成有利于细菌过度生长的免疫抑制环境。
要点
- 小鼠大肠埃希菌肺炎模型中,细菌接种后30分钟给予丙戊酸250 mg/kg可减少中性粒细胞流入肺部并降低髓过氧化物酶活性。
- 丙戊酸减轻肺部及全身炎症反应,基本预防ARDS,但肺实质细菌增殖增加。
- 该模型提示组蛋白去乙酰化酶抑制剂类药物的抗炎作用可能以削弱细菌清除为代价。
- 研究为动物实验(雄性C57BL6小鼠,n=24),结果不能直接外推至临床患者。
适用人群与场景
- 雄性C57BL6小鼠(n=24),经气管滴注3×10大肠埃希菌诱导肺炎相关ARDS的动物模型。
处置流程与药物剂量
- 干预组在气管滴注大肠埃希菌后30分钟给予丙戊酸250 mg/kg。
研究设计与关键结果
- 研究类型为动物实验,样本为雄性C57BL6小鼠n=24,经气管滴注3×10大肠埃希菌诱导ARDS。
- 丙戊酸(250 mg/kg)于细菌滴注后30分钟给药,减少中性粒细胞流入肺部并降低髓过氧化物酶活性,减轻局部组织破坏。
- 丙戊酸改善肺部及全身炎症反应,基本预防ARDS,但导致肺实质细菌增殖增加。
证据类型、等级与局限
- 证据类型为动物实验(小鼠模型)。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,在临床相关细菌性ARDS小鼠模型中,丙戊酸虽减轻宿主炎症反应、基本预防ARDS,但造成有利于细菌过度生长的免疫抑制环境。
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Histone deacetylase inhibitors (HDACI) are members of a family of epigenetic modifying agents with broad anti-inflammatory properties. These anti-inflammatory properties may have important therapeutic implications in acute respiratory distress syndrome (ARDS). However, administration of HDACI may create an immunosuppressive environment conducive to bacterial growth. Accordingly, the aim of the current study is to investigate the effect of HDACI valproic acid (VPA) on host inflammatory response and bacterial burden in a murine model of Escherichia coli pneumonia-induced ARDS.
METHODS: ARDS was induced in male C57BL6 mice (n = 24) by endotracheal instillation of 3 × 10 E. coli. VPA (250 mg/kg) was administered 30 minutes after E. coli instillation in the intervention group. Blood samples were collected at 3 and 6 hours, and animals were sacrificed at 6 hours. Bronchoalveolar lavage (BAL) was performed, and tissue specimens were harvested. Cytokine levels were measured in blood and BAL, and so was transalveolar protein transit. Cell counts and colony forming units were quantified in BAL fluid.
RESULTS: VPA reduced neutrophil influx into the lungs and local tissue destruction through decreased myeloperoxidase activity. It also ameliorated the pulmonary and systemic inflammatory response. This led to greater bacterial proliferation in the pulmonary parenchyma.
CONCLUSION: Administration of VPA in a clinically relevant bacterial model of murine ARDS mitigates the host inflammatory response, essentially preventing ARDS, but creates an immunosuppressive environment that favors bacterial overgrowth.
参考来源
- Kasotakis G, Galvan M, King E, et al. Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance. J Trauma Acute Care Surg. 2017. PMID: 28099388. doi:10.1097/TA.0000000000001389
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。